Table 2.
Whole cohort | p-value (vs. GTV) | Median CI (GTV) [%] | Lung | p-value (vs. GTV) | Median CI (GTV) [%] | Oesophageal | p-value (vs. GTV) | Median CI (GTV) [%] | Pelvic | p-value (vs. GTV) | Median CI (GTV) [%] | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Manual |
|
|
|
|
|
|
|
|
|
|
|
|
GTV [ml] |
43.7 |
-- |
-- |
81.1 |
-- |
-- |
34.2 |
-- |
-- |
70.4 |
-- |
-- |
SUV(38%) [ml] |
29.2 |
0.04 |
32.9 |
30.9 |
0.33 |
24.0 |
15.2 |
0.04 |
51.9 |
28.7 |
0.24 |
29.8 |
SUV(42%) [ml] |
23.8 |
0.02 |
30.0 |
25.4 |
0.21 |
25.5 |
13.8 |
0.04 |
47.6 |
26.0 |
0.24 |
27.2 |
SUV(47%) [ml] |
19.3 |
<0.001 |
37.8 |
17.1 |
0.04 |
24.2 |
12.0 |
0.04 |
41.8 |
22.5 |
0.03 |
39.4 |
SUV(50%) [ml] |
14.5 |
<0.001 |
33.3 |
14.3 |
0.03 |
20.5 |
11.4 |
0.04 |
38.7 |
22.0 |
0.02 |
34.5 |
PERCIST TLG [ml] | 19.8 | 0.01 | 35.3 | 12.8 | 0.02 | 30.0 | 30.3 | 0.69 | 56.4 | 15.3 | 0.27 | 24.9 |